Strata Critical Medical, Inc.

For the period ended Mar 31, 2026. Filed May 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

SRTA$6.05+8.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Cover page Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial statements

Unaudited Interim Condensed Consolidated Balance Sheets as of March 31, and December 31,Unaudited Interim Notes to Unaudited Interim Item 2. Management’s discussion and analysis of financial condition and results of operations Item 3. Quantitative and qualitative disclosures about market risk Item 4. Controls and procedures

PART II. OTHER INFORMATION

Legal proceedings Item 1A. Risk factors

Item 2. Unregistered sales of equity securities, use of proceeds and Issuer purchases of equity securities (no text here)

Item 3. Defaults upon senior securities (no text here)

Item 4. Mine safety disclosures (no text here)

Item 5. Other information Item 6. Exhibits SIGNATURES

FORM 10-Q

TABLE OF CONTENTS

Page
PART I. FINANCIAL INFORMATION	3
Item 1.	Financial statements	3
	Unaudited Interim Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025	3
	Unaudited Interim Condensed Consolidated Statements of Operations for the three months ended March 31, 2026 and 2025	4
	Unaudited Interim Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2026 and 2025	5
	Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2026 and 2025	6
	Unaudited Interim Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025	7
	Notes to Unaudited Interim Condensed Consolidated Financial Statements	8
Item 2.	Management’s discussion and analysis of financial condition and results of operations	23
Item 3.	Quantitative and qualitative disclosures about market risk	37
Item 4.	Controls and procedures	37
PART II. OTHER INFORMATION	38
Item 1.	Legal proceedings	38
Item 1A.	Risk factors	38
Item 2.	Unregistered sales of equity securities, use of proceeds and Issuer purchases of equity securities	38
Item 3.	Defaults upon senior securities	38
Item 4.	Mine safety disclosures	38
Item 5.	Other information	38
Item 6.	Exhibits	39
SIGNATURES	40

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.